RECRUITING

Discharge Medication Use Post-Operatively in GU Cancer Patients

Conditions

Genitourinary Cancer Cystectomies Nephrectomies Prostatectomies

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.

Official Title

Discharge Medication Use Post-Operatively in GU Cancer Patients

Quick Facts

Study Start:2025-02-21

Study Completion:2026-07

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06795087

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Written informed consent and HIPAA authorization for release of personal health information. 2. Age ≥ 18 years at the time of enrollment 3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis. 4. Ability to read and understand the English and/or Spanish language. 5. Enrolling investigator plans to prescribe opioids at the time of discharge for post-operative pain. 6. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.	* None

Inclusion Criteria

Exclusion Criteria

1. Written informed consent and HIPAA authorization for release of personal health information.
2. Age ≥ 18 years at the time of enrollment
3. Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
4. Ability to read and understand the English and/or Spanish language.
5. Enrolling investigator plans to prescribe opioids at the time of discharge for post-operative pain.
6. As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.

* None

Contacts and Locations

Study Contact

Alicia Patrick

CONTACT

980-292-1746

Alicia.Patrick@atriumhealth.org

Principal Investigator

Stephen Riggs, MD

PRINCIPAL_INVESTIGATOR

Wake Forest University Health Sciences

Study Locations (Sites)

Levine Cancer Institute

Charlotte, North Carolina, 28204

United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

Stephen Riggs, MD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-21

Study Completion Date2026-07

Study Record Updates

Study Start Date2025-02-21

Study Completion Date2026-07

Terms related to this study

Keywords Provided by Researchers

Genitourinary Cancer
Cystectomies
Nephrectomies
Prostatectomies

Additional Relevant MeSH Terms

Genitourinary Cancer